Q2 2024 EPS Estimates for TG Therapeutics, Inc. Increased by Analyst (NASDAQ:TGTX) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics, Inc. Forecasted to Post FY2025 Earnings of $0.11 Per Share (NASDAQ:TGTX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Head to Head Analysis: PainReform (NASDAQ:PRFX) vs. TG Therapeutics (NASDAQ:TGTX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ:TGTX – Free Report) had its price objective increased by HC Wainwright from $45.00 to $49.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other analysts have also recently issued reports on the stock. The Goldman Sachs […]
HC Wainwright Raises TG Therapeutics (NASDAQ:TGTX) Price Target to $49.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ:TGTX – Get Free Report) had its price target boosted by research analysts at HC Wainwright from $45.00 to $49.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 202.66% from the company’s […]
TG Therapeutics (NASDAQ:TGTX – Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02), Briefing.com reports. The company had revenue of $63.47 million during the quarter, compared to analyst estimates of $54.60 million. TG Therapeutics had a net […]
Israel-headquartered IM Cannabis Corp. (IMCC) engaged in the business of medical cannabis products is up mofre than 36 % in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.